Atea Pharmaceuticals (AVIR) Tax Rate (2021 - 2026)

Atea Pharmaceuticals' Tax Rate history runs 6 years deep, the most recent figure standing at 0.11% for Q1 2026.

• On a quarterly basis, Tax Rate rose 49.0% year-over-year to 0.11% in Q1 2026; TTM through Mar 2026 was 3.59%, a 424.0% increase from a year earlier, with the FY2025 full-year figure at 3.75%, up 430.0% from the prior year.
• Tax Rate eased to 0.11% in Q1 2026 per AVIR's latest filing, from 13.11% in the prior quarter.
• Across five years, Tax Rate topped out at 32.21% in Q3 2022 and bottomed at 0.9% in Q4 2023.
• The 5-year median for Tax Rate is 0.56% (2025), against an average of 2.34%.
• Biggest YoY gain for Tax Rate was 5982 bps in 2022; the steepest drop was 8277 bps in 2022.
• Year by year, Tax Rate stood at 0.36% in 2022, then slumped by 151 bps to 0.9% in 2023, then grew by 25 bps to 0.68% in 2024, then jumped by 2041 bps to 13.11% in 2025, then sank by 101 bps to 0.11% in 2026.
• Per Business Quant, the three latest AVIR Tax Rate figures stand at 0.11% (Q1 2026), 13.11% (Q4 2025), and 0.47% (Q3 2025).